Overview

Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae

Status:
Recruiting
Trial end date:
2028-02-28
Target enrollment:
Participant gender:
Summary
Determine safety and feasibility of using institutionally prepared autologous, uncultured SVF on patients with aerodigestive and enterocutaneous fistulae secondary to malignancy, trauma or surgery.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic